nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—HTR1F—GPCRs, Other—PTGFR—glaucoma	0.00214	0.0387	CbGpPWpGaD
Naratriptan—MAOA—Dopamine metabolism—SOD1—glaucoma	0.00209	0.0378	CbGpPWpGaD
Naratriptan—MAOA—Neurotransmitter Release Cycle—SLC6A13—glaucoma	0.00181	0.0327	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.0014	0.0254	CbGpPWpGaD
Naratriptan—MAOA—Neurotransmitter Release Cycle—SLC6A1—glaucoma	0.00132	0.0239	CbGpPWpGaD
Naratriptan—MAOA—Melatonin metabolism and effects—CYP1B1—glaucoma	0.00123	0.0223	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00119	0.0216	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00113	0.0204	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Other—SMO—glaucoma	0.00108	0.0195	CbGpPWpGaD
Naratriptan—MAOA—Oxidative Stress—SOD1—glaucoma	0.00107	0.0193	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00103	0.0187	CbGpPWpGaD
Naratriptan—MAOA—Melatonin metabolism and effects—EDN1—glaucoma	0.000998	0.018	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000931	0.0168	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000886	0.016	CbGpPWpGaD
Naratriptan—MAOA—Melatonin metabolism and effects—APOE—glaucoma	0.000812	0.0147	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000798	0.0144	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000723	0.0131	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000708	0.0128	CbGpPWpGaD
Naratriptan—Somnolence—Dorzolamide—glaucoma	0.000676	0.000716	CcSEcCtD
Naratriptan—Muscle spasms—Clonidine—glaucoma	0.000676	0.000716	CcSEcCtD
Naratriptan—Dyspnoea—Travoprost—glaucoma	0.000675	0.000715	CcSEcCtD
Naratriptan—HTR1F—GPCR ligand binding—OPN4—glaucoma	0.000675	0.0122	CbGpPWpGaD
Naratriptan—Hypotension—Pilocarpine—glaucoma	0.000672	0.000711	CcSEcCtD
Naratriptan—Paraesthesia—Brinzolamide—glaucoma	0.000672	0.000711	CcSEcCtD
Naratriptan—Dyspnoea—Brinzolamide—glaucoma	0.000667	0.000706	CcSEcCtD
Naratriptan—Asthenia—Apraclonidine—glaucoma	0.000666	0.000705	CcSEcCtD
Naratriptan—Somnolence—Brinzolamide—glaucoma	0.000665	0.000704	CcSEcCtD
Naratriptan—Vision blurred—Clonidine—glaucoma	0.000663	0.000702	CcSEcCtD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000661	0.0119	CbGpPWpGaD
Naratriptan—Urticaria—Acetazolamide—glaucoma	0.000659	0.000698	CcSEcCtD
Naratriptan—Tremor—Clonidine—glaucoma	0.000659	0.000698	CcSEcCtD
Naratriptan—Pruritus—Apraclonidine—glaucoma	0.000657	0.000695	CcSEcCtD
Naratriptan—Body temperature increased—Acetazolamide—glaucoma	0.000656	0.000695	CcSEcCtD
Naratriptan—Fatigue—Dorzolamide—glaucoma	0.000656	0.000694	CcSEcCtD
Naratriptan—Tinnitus—Betaxolol—glaucoma	0.000656	0.000694	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000655	0.000693	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Travoprost—glaucoma	0.000654	0.000692	CcSEcCtD
Naratriptan—Fatigue—Travoprost—glaucoma	0.000653	0.000691	CcSEcCtD
Naratriptan—Cardiac disorder—Betaxolol—glaucoma	0.000653	0.000691	CcSEcCtD
Naratriptan—Ill-defined disorder—Clonidine—glaucoma	0.000653	0.000691	CcSEcCtD
Naratriptan—Pain—Dorzolamide—glaucoma	0.000651	0.000689	CcSEcCtD
Naratriptan—Constipation—Travoprost—glaucoma	0.000648	0.000686	CcSEcCtD
Naratriptan—Pain—Travoprost—glaucoma	0.000648	0.000686	CcSEcCtD
Naratriptan—Hyperglycaemia—Timolol—glaucoma	0.000648	0.000686	CcSEcCtD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000647	0.0117	CbGpPWpGaD
Naratriptan—Agitation—Clonidine—glaucoma	0.000647	0.000684	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000646	0.000684	CcSEcCtD
Naratriptan—Paraesthesia—Pilocarpine—glaucoma	0.000646	0.000683	CcSEcCtD
Naratriptan—Asthenia—Bimatoprost—glaucoma	0.000646	0.000683	CcSEcCtD
Naratriptan—Fatigue—Brinzolamide—glaucoma	0.000645	0.000683	CcSEcCtD
Naratriptan—Dyspnoea—Pilocarpine—glaucoma	0.000641	0.000679	CcSEcCtD
Naratriptan—Pain—Brinzolamide—glaucoma	0.00064	0.000677	CcSEcCtD
Naratriptan—Somnolence—Pilocarpine—glaucoma	0.000639	0.000677	CcSEcCtD
Naratriptan—Depression—Timolol—glaucoma	0.000638	0.000676	CcSEcCtD
Naratriptan—Angiopathy—Betaxolol—glaucoma	0.000638	0.000676	CcSEcCtD
Naratriptan—Pruritus—Bimatoprost—glaucoma	0.000637	0.000674	CcSEcCtD
Naratriptan—Immune system disorder—Betaxolol—glaucoma	0.000636	0.000673	CcSEcCtD
Naratriptan—Diarrhoea—Apraclonidine—glaucoma	0.000635	0.000672	CcSEcCtD
Naratriptan—Malaise—Clonidine—glaucoma	0.000634	0.000672	CcSEcCtD
Naratriptan—Chills—Betaxolol—glaucoma	0.000631	0.000668	CcSEcCtD
Naratriptan—Syncope—Clonidine—glaucoma	0.000631	0.000668	CcSEcCtD
Naratriptan—Arrhythmia—Betaxolol—glaucoma	0.000629	0.000665	CcSEcCtD
Naratriptan—Feeling abnormal—Dorzolamide—glaucoma	0.000627	0.000664	CcSEcCtD
Naratriptan—Feeling abnormal—Travoprost—glaucoma	0.000624	0.000661	CcSEcCtD
Naratriptan—Alopecia—Betaxolol—glaucoma	0.000622	0.000658	CcSEcCtD
Naratriptan—Palpitations—Clonidine—glaucoma	0.000622	0.000658	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000621	0.000657	CcSEcCtD
Naratriptan—Loss of consciousness—Clonidine—glaucoma	0.000618	0.000655	CcSEcCtD
Naratriptan—Feeling abnormal—Brinzolamide—glaucoma	0.000616	0.000653	CcSEcCtD
Naratriptan—Constipation—Pilocarpine—glaucoma	0.000615	0.000651	CcSEcCtD
Naratriptan—Pain—Pilocarpine—glaucoma	0.000615	0.000651	CcSEcCtD
Naratriptan—Cough—Clonidine—glaucoma	0.000614	0.00065	CcSEcCtD
Naratriptan—Sweating—Timolol—glaucoma	0.000614	0.00065	CcSEcCtD
Naratriptan—Dizziness—Apraclonidine—glaucoma	0.000614	0.00065	CcSEcCtD
Naratriptan—Erythema—Betaxolol—glaucoma	0.000613	0.000648	CcSEcCtD
Naratriptan—HTR1F—GPCR ligand binding—PTGFR—glaucoma	0.000607	0.011	CbGpPWpGaD
Naratriptan—Urticaria—Dorzolamide—glaucoma	0.000604	0.00064	CcSEcCtD
Naratriptan—Body temperature increased—Dorzolamide—glaucoma	0.000602	0.000637	CcSEcCtD
Naratriptan—Sinusitis—Timolol—glaucoma	0.000601	0.000636	CcSEcCtD
Naratriptan—Arthralgia—Clonidine—glaucoma	0.000599	0.000634	CcSEcCtD
Naratriptan—Anxiety—Clonidine—glaucoma	0.000597	0.000632	CcSEcCtD
Naratriptan—Asthenia—Acetazolamide—glaucoma	0.000596	0.000631	CcSEcCtD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000595	0.0108	CbGpPWpGaD
Naratriptan—Dizziness—Bimatoprost—glaucoma	0.000595	0.00063	CcSEcCtD
Naratriptan—Urticaria—Brinzolamide—glaucoma	0.000594	0.000629	CcSEcCtD
Naratriptan—Feeling abnormal—Pilocarpine—glaucoma	0.000593	0.000627	CcSEcCtD
Naratriptan—Discomfort—Clonidine—glaucoma	0.000592	0.000626	CcSEcCtD
Naratriptan—Vomiting—Apraclonidine—glaucoma	0.00059	0.000625	CcSEcCtD
Naratriptan—Muscle spasms—Betaxolol—glaucoma	0.000589	0.000623	CcSEcCtD
Naratriptan—Hypersensitivity—Brimonidine—glaucoma	0.000587	0.000621	CcSEcCtD
Naratriptan—Dry mouth—Clonidine—glaucoma	0.000586	0.00062	CcSEcCtD
Naratriptan—Bradycardia—Timolol—glaucoma	0.000585	0.000619	CcSEcCtD
Naratriptan—Dermatitis—Apraclonidine—glaucoma	0.000585	0.000619	CcSEcCtD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000583	0.0105	CbGpPWpGaD
Naratriptan—Headache—Apraclonidine—glaucoma	0.000581	0.000615	CcSEcCtD
Naratriptan—Confusional state—Clonidine—glaucoma	0.000579	0.000613	CcSEcCtD
Naratriptan—Vision blurred—Betaxolol—glaucoma	0.000577	0.000611	CcSEcCtD
Naratriptan—Oedema—Clonidine—glaucoma	0.000574	0.000608	CcSEcCtD
Naratriptan—Tremor—Betaxolol—glaucoma	0.000574	0.000607	CcSEcCtD
Naratriptan—Hallucination—Timolol—glaucoma	0.000572	0.000605	CcSEcCtD
Naratriptan—Asthenia—Brimonidine—glaucoma	0.000572	0.000605	CcSEcCtD
Naratriptan—Infection—Clonidine—glaucoma	0.00057	0.000604	CcSEcCtD
Naratriptan—Body temperature increased—Pilocarpine—glaucoma	0.000568	0.000602	CcSEcCtD
Naratriptan—Ill-defined disorder—Betaxolol—glaucoma	0.000568	0.000602	CcSEcCtD
Naratriptan—Diarrhoea—Acetazolamide—glaucoma	0.000568	0.000601	CcSEcCtD
Naratriptan—Rash—Bimatoprost—glaucoma	0.000567	0.000601	CcSEcCtD
Naratriptan—Dermatitis—Bimatoprost—glaucoma	0.000567	0.0006	CcSEcCtD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000566	0.0102	CbGpPWpGaD
Naratriptan—Anaemia—Betaxolol—glaucoma	0.000566	0.000599	CcSEcCtD
Naratriptan—Shock—Clonidine—glaucoma	0.000565	0.000598	CcSEcCtD
Naratriptan—Pruritus—Brimonidine—glaucoma	0.000564	0.000597	CcSEcCtD
Naratriptan—Headache—Bimatoprost—glaucoma	0.000564	0.000597	CcSEcCtD
Naratriptan—Nervous system disorder—Clonidine—glaucoma	0.000563	0.000596	CcSEcCtD
Naratriptan—Thrombocytopenia—Clonidine—glaucoma	0.000562	0.000595	CcSEcCtD
Naratriptan—Hypersensitivity—Dorzolamide—glaucoma	0.000561	0.000593	CcSEcCtD
Naratriptan—MAOA—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000559	0.0101	CbGpPWpGaD
Naratriptan—Hypersensitivity—Travoprost—glaucoma	0.000558	0.000591	CcSEcCtD
Naratriptan—Skin disorder—Clonidine—glaucoma	0.000558	0.00059	CcSEcCtD
Naratriptan—Hyperhidrosis—Clonidine—glaucoma	0.000555	0.000588	CcSEcCtD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000555	0.01	CbGpPWpGaD
Naratriptan—Malaise—Betaxolol—glaucoma	0.000552	0.000585	CcSEcCtD
Naratriptan—Nausea—Apraclonidine—glaucoma	0.000551	0.000584	CcSEcCtD
Naratriptan—Hypersensitivity—Brinzolamide—glaucoma	0.000551	0.000583	CcSEcCtD
Naratriptan—Vertigo—Betaxolol—glaucoma	0.00055	0.000583	CcSEcCtD
Naratriptan—Syncope—Betaxolol—glaucoma	0.000549	0.000581	CcSEcCtD
Naratriptan—Dizziness—Acetazolamide—glaucoma	0.000549	0.000581	CcSEcCtD
Naratriptan—Asthenia—Dorzolamide—glaucoma	0.000546	0.000578	CcSEcCtD
Naratriptan—Asthenia—Travoprost—glaucoma	0.000544	0.000575	CcSEcCtD
Naratriptan—Palpitations—Betaxolol—glaucoma	0.000541	0.000573	CcSEcCtD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000539	0.00974	CbGpPWpGaD
Naratriptan—Pruritus—Dorzolamide—glaucoma	0.000538	0.00057	CcSEcCtD
Naratriptan—Loss of consciousness—Betaxolol—glaucoma	0.000538	0.00057	CcSEcCtD
Naratriptan—Asthenia—Brinzolamide—glaucoma	0.000537	0.000568	CcSEcCtD
Naratriptan—Hypotension—Clonidine—glaucoma	0.000537	0.000568	CcSEcCtD
Naratriptan—Pruritus—Travoprost—glaucoma	0.000536	0.000567	CcSEcCtD
Naratriptan—Tinnitus—Timolol—glaucoma	0.000536	0.000567	CcSEcCtD
Naratriptan—Cough—Betaxolol—glaucoma	0.000534	0.000566	CcSEcCtD
Naratriptan—Nausea—Bimatoprost—glaucoma	0.000534	0.000566	CcSEcCtD
Naratriptan—Cardiac disorder—Timolol—glaucoma	0.000533	0.000565	CcSEcCtD
Naratriptan—Hypersensitivity—Pilocarpine—glaucoma	0.00053	0.000561	CcSEcCtD
Naratriptan—Pruritus—Brinzolamide—glaucoma	0.000529	0.00056	CcSEcCtD
Naratriptan—Vomiting—Acetazolamide—glaucoma	0.000528	0.000559	CcSEcCtD
Naratriptan—Dizziness—Brimonidine—glaucoma	0.000527	0.000558	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Clonidine—glaucoma	0.000523	0.000554	CcSEcCtD
Naratriptan—Angiopathy—Timolol—glaucoma	0.000522	0.000552	CcSEcCtD
Naratriptan—Myalgia—Betaxolol—glaucoma	0.000521	0.000552	CcSEcCtD
Naratriptan—Arthralgia—Betaxolol—glaucoma	0.000521	0.000552	CcSEcCtD
Naratriptan—Diarrhoea—Dorzolamide—glaucoma	0.000521	0.000551	CcSEcCtD
Naratriptan—Headache—Acetazolamide—glaucoma	0.00052	0.000551	CcSEcCtD
Naratriptan—Anxiety—Betaxolol—glaucoma	0.00052	0.00055	CcSEcCtD
Naratriptan—Immune system disorder—Timolol—glaucoma	0.000519	0.00055	CcSEcCtD
Naratriptan—MAOA—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000519	0.00938	CbGpPWpGaD
Naratriptan—Diarrhoea—Travoprost—glaucoma	0.000518	0.000549	CcSEcCtD
Naratriptan—Asthenia—Pilocarpine—glaucoma	0.000516	0.000546	CcSEcCtD
Naratriptan—Paraesthesia—Clonidine—glaucoma	0.000516	0.000546	CcSEcCtD
Naratriptan—Discomfort—Betaxolol—glaucoma	0.000515	0.000545	CcSEcCtD
Naratriptan—Arrhythmia—Timolol—glaucoma	0.000513	0.000544	CcSEcCtD
Naratriptan—Dyspnoea—Clonidine—glaucoma	0.000512	0.000542	CcSEcCtD
Naratriptan—Diarrhoea—Brinzolamide—glaucoma	0.000512	0.000542	CcSEcCtD
Naratriptan—Somnolence—Clonidine—glaucoma	0.00051	0.00054	CcSEcCtD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00051	0.00922	CbGpPWpGaD
Naratriptan—Dry mouth—Betaxolol—glaucoma	0.00051	0.00054	CcSEcCtD
Naratriptan—Pruritus—Pilocarpine—glaucoma	0.000509	0.000538	CcSEcCtD
Naratriptan—Alopecia—Timolol—glaucoma	0.000508	0.000538	CcSEcCtD
Naratriptan—Confusional state—Betaxolol—glaucoma	0.000504	0.000534	CcSEcCtD
Naratriptan—MAOA—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000503	0.0091	CbGpPWpGaD
Naratriptan—Dizziness—Dorzolamide—glaucoma	0.000503	0.000533	CcSEcCtD
Naratriptan—Rash—Brimonidine—glaucoma	0.000502	0.000532	CcSEcCtD
Naratriptan—Dermatitis—Brimonidine—glaucoma	0.000502	0.000531	CcSEcCtD
Naratriptan—Dizziness—Travoprost—glaucoma	0.000501	0.00053	CcSEcCtD
Naratriptan—Erythema—Timolol—glaucoma	0.0005	0.00053	CcSEcCtD
Naratriptan—Oedema—Betaxolol—glaucoma	0.0005	0.000529	CcSEcCtD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000499	0.00902	CbGpPWpGaD
Naratriptan—Headache—Brimonidine—glaucoma	0.000499	0.000528	CcSEcCtD
Naratriptan—Infection—Betaxolol—glaucoma	0.000497	0.000526	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Clonidine—glaucoma	0.000496	0.000525	CcSEcCtD
Naratriptan—Fatigue—Clonidine—glaucoma	0.000495	0.000524	CcSEcCtD
Naratriptan—Dizziness—Brinzolamide—glaucoma	0.000495	0.000524	CcSEcCtD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000493	0.00891	CbGpPWpGaD
Naratriptan—Nausea—Acetazolamide—glaucoma	0.000493	0.000522	CcSEcCtD
Naratriptan—Diarrhoea—Pilocarpine—glaucoma	0.000492	0.000521	CcSEcCtD
Naratriptan—Shock—Betaxolol—glaucoma	0.000492	0.000521	CcSEcCtD
Naratriptan—Constipation—Clonidine—glaucoma	0.000491	0.00052	CcSEcCtD
Naratriptan—Pain—Clonidine—glaucoma	0.000491	0.00052	CcSEcCtD
Naratriptan—Nervous system disorder—Betaxolol—glaucoma	0.00049	0.000519	CcSEcCtD
Naratriptan—Thrombocytopenia—Betaxolol—glaucoma	0.000489	0.000518	CcSEcCtD
Naratriptan—Skin disorder—Betaxolol—glaucoma	0.000486	0.000514	CcSEcCtD
Naratriptan—Vomiting—Dorzolamide—glaucoma	0.000484	0.000512	CcSEcCtD
Naratriptan—Hyperhidrosis—Betaxolol—glaucoma	0.000483	0.000512	CcSEcCtD
Naratriptan—Rash—Dorzolamide—glaucoma	0.00048	0.000508	CcSEcCtD
Naratriptan—Dermatitis—Dorzolamide—glaucoma	0.000479	0.000507	CcSEcCtD
Naratriptan—Rash—Travoprost—glaucoma	0.000478	0.000506	CcSEcCtD
Naratriptan—Dermatitis—Travoprost—glaucoma	0.000477	0.000505	CcSEcCtD
Naratriptan—Headache—Dorzolamide—glaucoma	0.000477	0.000505	CcSEcCtD
Naratriptan—Vomiting—Brinzolamide—glaucoma	0.000476	0.000503	CcSEcCtD
Naratriptan—Dizziness—Pilocarpine—glaucoma	0.000475	0.000503	CcSEcCtD
Naratriptan—Headache—Travoprost—glaucoma	0.000475	0.000502	CcSEcCtD
Naratriptan—Nausea—Brimonidine—glaucoma	0.000473	0.000501	CcSEcCtD
Naratriptan—Feeling abnormal—Clonidine—glaucoma	0.000473	0.000501	CcSEcCtD
Naratriptan—Rash—Brinzolamide—glaucoma	0.000472	0.000499	CcSEcCtD
Naratriptan—Vision blurred—Timolol—glaucoma	0.000472	0.000499	CcSEcCtD
Naratriptan—Dermatitis—Brinzolamide—glaucoma	0.000471	0.000499	CcSEcCtD
Naratriptan—Headache—Brinzolamide—glaucoma	0.000469	0.000496	CcSEcCtD
Naratriptan—Hypotension—Betaxolol—glaucoma	0.000467	0.000494	CcSEcCtD
Naratriptan—Vomiting—Pilocarpine—glaucoma	0.000457	0.000484	CcSEcCtD
Naratriptan—Urticaria—Clonidine—glaucoma	0.000456	0.000483	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000455	0.000482	CcSEcCtD
Naratriptan—Body temperature increased—Clonidine—glaucoma	0.000454	0.00048	CcSEcCtD
Naratriptan—Rash—Pilocarpine—glaucoma	0.000453	0.00048	CcSEcCtD
Naratriptan—Dermatitis—Pilocarpine—glaucoma	0.000453	0.000479	CcSEcCtD
Naratriptan—Nausea—Dorzolamide—glaucoma	0.000452	0.000478	CcSEcCtD
Naratriptan—Headache—Pilocarpine—glaucoma	0.00045	0.000477	CcSEcCtD
Naratriptan—Nausea—Travoprost—glaucoma	0.00045	0.000476	CcSEcCtD
Naratriptan—Vertigo—Timolol—glaucoma	0.00045	0.000476	CcSEcCtD
Naratriptan—Paraesthesia—Betaxolol—glaucoma	0.000449	0.000475	CcSEcCtD
Naratriptan—Syncope—Timolol—glaucoma	0.000449	0.000475	CcSEcCtD
Naratriptan—Dyspnoea—Betaxolol—glaucoma	0.000446	0.000472	CcSEcCtD
Naratriptan—Nausea—Brinzolamide—glaucoma	0.000444	0.00047	CcSEcCtD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000444	0.00802	CbGpPWpGaD
Naratriptan—Palpitations—Timolol—glaucoma	0.000442	0.000468	CcSEcCtD
Naratriptan—Loss of consciousness—Timolol—glaucoma	0.00044	0.000466	CcSEcCtD
Naratriptan—Cough—Timolol—glaucoma	0.000437	0.000462	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Betaxolol—glaucoma	0.000432	0.000457	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—OPN4—glaucoma	0.000431	0.00779	CbGpPWpGaD
Naratriptan—Fatigue—Betaxolol—glaucoma	0.000431	0.000456	CcSEcCtD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000428	0.00773	CbGpPWpGaD
Naratriptan—Pain—Betaxolol—glaucoma	0.000427	0.000453	CcSEcCtD
Naratriptan—Constipation—Betaxolol—glaucoma	0.000427	0.000453	CcSEcCtD
Naratriptan—Nausea—Pilocarpine—glaucoma	0.000427	0.000452	CcSEcCtD
Naratriptan—Myalgia—Timolol—glaucoma	0.000426	0.000451	CcSEcCtD
Naratriptan—Arthralgia—Timolol—glaucoma	0.000426	0.000451	CcSEcCtD
Naratriptan—Anxiety—Timolol—glaucoma	0.000425	0.000449	CcSEcCtD
Naratriptan—Hypersensitivity—Clonidine—glaucoma	0.000423	0.000448	CcSEcCtD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000423	0.00764	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—OPN4—glaucoma	0.000422	0.00763	CbGpPWpGaD
Naratriptan—Discomfort—Timolol—glaucoma	0.000421	0.000446	CcSEcCtD
Naratriptan—Dry mouth—Timolol—glaucoma	0.000417	0.000441	CcSEcCtD
Naratriptan—Asthenia—Clonidine—glaucoma	0.000412	0.000436	CcSEcCtD
Naratriptan—Feeling abnormal—Betaxolol—glaucoma	0.000412	0.000436	CcSEcCtD
Naratriptan—Confusional state—Timolol—glaucoma	0.000412	0.000436	CcSEcCtD
Naratriptan—Anaphylactic shock—Timolol—glaucoma	0.000408	0.000432	CcSEcCtD
Naratriptan—Oedema—Timolol—glaucoma	0.000408	0.000432	CcSEcCtD
Naratriptan—Pruritus—Clonidine—glaucoma	0.000406	0.00043	CcSEcCtD
Naratriptan—Infection—Timolol—glaucoma	0.000406	0.000429	CcSEcCtD
Naratriptan—Shock—Timolol—glaucoma	0.000402	0.000425	CcSEcCtD
Naratriptan—Nervous system disorder—Timolol—glaucoma	0.0004	0.000424	CcSEcCtD
Naratriptan—MAOA—Neuronal System—SLC6A13—glaucoma	0.000398	0.00718	CbGpPWpGaD
Naratriptan—Urticaria—Betaxolol—glaucoma	0.000397	0.00042	CcSEcCtD
Naratriptan—Skin disorder—Timolol—glaucoma	0.000397	0.00042	CcSEcCtD
Naratriptan—Body temperature increased—Betaxolol—glaucoma	0.000395	0.000418	CcSEcCtD
Naratriptan—Hyperhidrosis—Timolol—glaucoma	0.000395	0.000418	CcSEcCtD
Naratriptan—Diarrhoea—Clonidine—glaucoma	0.000393	0.000416	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—PTGFR—glaucoma	0.000388	0.00702	CbGpPWpGaD
Naratriptan—Hypotension—Timolol—glaucoma	0.000382	0.000404	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—OPN4—glaucoma	0.000381	0.00689	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00038	0.00687	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—PTGFR—glaucoma	0.00038	0.00687	CbGpPWpGaD
Naratriptan—MAOA—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.00038	0.00686	CbGpPWpGaD
Naratriptan—Dizziness—Clonidine—glaucoma	0.00038	0.000402	CcSEcCtD
Naratriptan—MAOA—Biological oxidations—GSTT1—glaucoma	0.000373	0.00674	CbGpPWpGaD
Naratriptan—Musculoskeletal discomfort—Timolol—glaucoma	0.000372	0.000394	CcSEcCtD
Naratriptan—Hypersensitivity—Betaxolol—glaucoma	0.000368	0.00039	CcSEcCtD
Naratriptan—Paraesthesia—Timolol—glaucoma	0.000367	0.000388	CcSEcCtD
Naratriptan—Vomiting—Clonidine—glaucoma	0.000365	0.000386	CcSEcCtD
Naratriptan—Dyspnoea—Timolol—glaucoma	0.000364	0.000385	CcSEcCtD
Naratriptan—Somnolence—Timolol—glaucoma	0.000363	0.000384	CcSEcCtD
Naratriptan—Rash—Clonidine—glaucoma	0.000362	0.000383	CcSEcCtD
Naratriptan—Dermatitis—Clonidine—glaucoma	0.000362	0.000383	CcSEcCtD
Naratriptan—MAOA—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00036	0.00651	CbGpPWpGaD
Naratriptan—Headache—Clonidine—glaucoma	0.00036	0.000381	CcSEcCtD
Naratriptan—Asthenia—Betaxolol—glaucoma	0.000359	0.00038	CcSEcCtD
Naratriptan—Pruritus—Betaxolol—glaucoma	0.000354	0.000374	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Timolol—glaucoma	0.000353	0.000373	CcSEcCtD
Naratriptan—Fatigue—Timolol—glaucoma	0.000352	0.000373	CcSEcCtD
Naratriptan—Pain—Timolol—glaucoma	0.000349	0.00037	CcSEcCtD
Naratriptan—HTR1F—Signaling by GPCR—OPN4—glaucoma	0.000346	0.00626	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—PTGFR—glaucoma	0.000343	0.0062	CbGpPWpGaD
Naratriptan—Diarrhoea—Betaxolol—glaucoma	0.000342	0.000362	CcSEcCtD
Naratriptan—Nausea—Clonidine—glaucoma	0.000341	0.000361	CcSEcCtD
Naratriptan—Feeling abnormal—Timolol—glaucoma	0.000337	0.000356	CcSEcCtD
Naratriptan—Dizziness—Betaxolol—glaucoma	0.000331	0.00035	CcSEcCtD
Naratriptan—Urticaria—Timolol—glaucoma	0.000324	0.000343	CcSEcCtD
Naratriptan—Body temperature increased—Timolol—glaucoma	0.000323	0.000342	CcSEcCtD
Naratriptan—HTR1A—GPCR ligand binding—OPN4—glaucoma	0.000322	0.00581	CbGpPWpGaD
Naratriptan—Vomiting—Betaxolol—glaucoma	0.000318	0.000336	CcSEcCtD
Naratriptan—Rash—Betaxolol—glaucoma	0.000315	0.000334	CcSEcCtD
Naratriptan—Dermatitis—Betaxolol—glaucoma	0.000315	0.000333	CcSEcCtD
Naratriptan—Headache—Betaxolol—glaucoma	0.000313	0.000332	CcSEcCtD
Naratriptan—HTR1F—Signaling by GPCR—PTGFR—glaucoma	0.000312	0.00563	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000306	0.00553	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—SMO—glaucoma	0.000306	0.00553	CbGpPWpGaD
Naratriptan—Hypersensitivity—Timolol—glaucoma	0.000301	0.000318	CcSEcCtD
Naratriptan—MAOA—Biological oxidations—CYP1B1—glaucoma	0.000297	0.00537	CbGpPWpGaD
Naratriptan—Nausea—Betaxolol—glaucoma	0.000297	0.000314	CcSEcCtD
Naratriptan—HTR1F—Signaling Pathways—LRP12—glaucoma	0.000295	0.00533	CbGpPWpGaD
Naratriptan—Asthenia—Timolol—glaucoma	0.000293	0.00031	CcSEcCtD
Naratriptan—HTR1F—G alpha (i) signalling events—C3—glaucoma	0.000291	0.00526	CbGpPWpGaD
Naratriptan—MAOA—Neuronal System—SLC6A1—glaucoma	0.000291	0.00526	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—PTGFR—glaucoma	0.00029	0.00524	CbGpPWpGaD
Naratriptan—Pruritus—Timolol—glaucoma	0.000289	0.000306	CcSEcCtD
Naratriptan—Diarrhoea—Timolol—glaucoma	0.000279	0.000296	CcSEcCtD
Naratriptan—Dizziness—Timolol—glaucoma	0.00027	0.000286	CcSEcCtD
Naratriptan—MAOA—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000269	0.00486	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000265	0.00479	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NARFL—glaucoma	0.000261	0.00472	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CA5A—glaucoma	0.000261	0.00472	CbGpPWpGaD
Naratriptan—Vomiting—Timolol—glaucoma	0.00026	0.000275	CcSEcCtD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000258	0.00467	CbGpPWpGaD
Naratriptan—Rash—Timolol—glaucoma	0.000257	0.000273	CcSEcCtD
Naratriptan—Dermatitis—Timolol—glaucoma	0.000257	0.000272	CcSEcCtD
Naratriptan—Headache—Timolol—glaucoma	0.000256	0.000271	CcSEcCtD
Naratriptan—HTR1D—GPCR downstream signaling—OPN4—glaucoma	0.000244	0.00441	CbGpPWpGaD
Naratriptan—Nausea—Timolol—glaucoma	0.000243	0.000257	CcSEcCtD
Naratriptan—HTR1B—GPCR downstream signaling—OPN4—glaucoma	0.000239	0.00431	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—NGF—glaucoma	0.000239	0.00431	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000238	0.00429	CbGpPWpGaD
Naratriptan—MAOA—Biological oxidations—GSTM1—glaucoma	0.000237	0.00429	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000232	0.00419	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000229	0.00413	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—OPN4—glaucoma	0.000221	0.004	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PTGFR—glaucoma	0.000219	0.00397	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000219	0.00397	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—OPN4—glaucoma	0.000217	0.00392	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PTGFR—glaucoma	0.000215	0.00388	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—OPN4—glaucoma	0.000204	0.0037	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—NGF—glaucoma	0.000203	0.00367	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000202	0.00365	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—EDN1—glaucoma	0.000202	0.00365	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PTGFR—glaucoma	0.000199	0.0036	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—SMO—glaucoma	0.000196	0.00354	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PTGFR—glaucoma	0.000195	0.00353	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—SMO—glaucoma	0.000192	0.00347	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HEYL—glaucoma	0.00019	0.00344	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LRP12—glaucoma	0.000189	0.00341	CbGpPWpGaD
Naratriptan—HTR1D—G alpha (i) signalling events—C3—glaucoma	0.000186	0.00337	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LRP12—glaucoma	0.000185	0.00334	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTGFR—glaucoma	0.000184	0.00333	CbGpPWpGaD
Naratriptan—HTR1B—G alpha (i) signalling events—C3—glaucoma	0.000182	0.0033	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—OPN4—glaucoma	0.000182	0.00329	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—C3—glaucoma	0.000176	0.00319	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00017	0.00306	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000166	0.003	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—OPN4—glaucoma	0.000165	0.00298	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PTGFR—glaucoma	0.000164	0.00296	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—SMO—glaucoma	0.000157	0.00284	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PTGFR—glaucoma	0.000149	0.00269	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000148	0.00268	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—SMO—glaucoma	0.000146	0.00264	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000145	0.00262	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—RPTOR—glaucoma	0.000144	0.0026	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LRP12—glaucoma	0.000141	0.00254	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NCK2—glaucoma	0.00014	0.00252	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—C3—glaucoma	0.000139	0.00251	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—OPN4—glaucoma	0.000131	0.00236	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—EDN1—glaucoma	0.000129	0.00233	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—OPN4—glaucoma	0.000128	0.00231	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CA1—glaucoma	0.000128	0.00231	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000126	0.00229	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—EDN1—glaucoma	0.000126	0.00228	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CTSA—glaucoma	0.000124	0.00223	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HEYL—glaucoma	0.000122	0.0022	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HEYL—glaucoma	0.000119	0.00215	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HDAC9—glaucoma	0.000119	0.00214	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTGFR—glaucoma	0.000118	0.00213	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CA2—glaucoma	0.000117	0.00211	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTGFR—glaucoma	0.000115	0.00208	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—EDN1—glaucoma	0.000114	0.00206	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000114	0.00206	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—C3—glaucoma	0.000113	0.00204	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00011	0.002	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—C3—glaucoma	0.00011	0.002	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—EDN1—glaucoma	0.000104	0.00187	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—SMO—glaucoma	0.0001	0.00182	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—C3—glaucoma	9.97e-05	0.0018	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—SMO—glaucoma	9.84e-05	0.00178	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TNF—glaucoma	9.77e-05	0.00177	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—OPN4—glaucoma	9.75e-05	0.00176	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—VEGFA—glaucoma	9.69e-05	0.00175	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—EDN1—glaucoma	9.63e-05	0.00174	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SMO—glaucoma	9.28e-05	0.00168	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RPTOR—glaucoma	9.21e-05	0.00166	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HEYL—glaucoma	9.07e-05	0.00164	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—C3—glaucoma	9.05e-05	0.00164	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RPTOR—glaucoma	9.02e-05	0.00163	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NCK2—glaucoma	8.92e-05	0.00161	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTGFR—glaucoma	8.78e-05	0.00159	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NCK2—glaucoma	8.74e-05	0.00158	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NTRK2—glaucoma	8.49e-05	0.00153	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—C3—glaucoma	8.41e-05	0.00152	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TNF—glaucoma	8.31e-05	0.0015	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—TXN—glaucoma	8.22e-05	0.00149	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HDAC9—glaucoma	7.59e-05	0.00137	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—SMO—glaucoma	7.5e-05	0.00135	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HDAC9—glaucoma	7.43e-05	0.00134	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—EDN1—glaucoma	7.3e-05	0.00132	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NGFR—glaucoma	7.28e-05	0.00132	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—EDN1—glaucoma	7.14e-05	0.00129	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NTRK1—glaucoma	6.92e-05	0.00125	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RPTOR—glaucoma	6.87e-05	0.00124	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NCK2—glaucoma	6.66e-05	0.0012	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—EDN1—glaucoma	6.63e-05	0.0012	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—EDN1—glaucoma	6.49e-05	0.00117	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CDKN2B—glaucoma	6.38e-05	0.00115	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GSTT1—glaucoma	6.37e-05	0.00115	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—C3—glaucoma	6.37e-05	0.00115	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—C3—glaucoma	6.24e-05	0.00113	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EDN1—glaucoma	6.12e-05	0.00111	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SMO—glaucoma	5.94e-05	0.00107	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SMO—glaucoma	5.81e-05	0.00105	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—C3—glaucoma	5.79e-05	0.00105	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—C3—glaucoma	5.67e-05	0.00102	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HDAC9—glaucoma	5.66e-05	0.00102	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NGF—glaucoma	5.62e-05	0.00102	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—EDN1—glaucoma	5.44e-05	0.000984	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NTRK2—glaucoma	5.43e-05	0.000981	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—C3—glaucoma	5.35e-05	0.000966	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NTRK2—glaucoma	5.32e-05	0.000961	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ABCA1—glaucoma	5.08e-05	0.000918	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYP1B1—glaucoma	5.08e-05	0.000918	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOE—glaucoma	4.98e-05	0.0009	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—EDN1—glaucoma	4.94e-05	0.000893	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CAV1—glaucoma	4.93e-05	0.000891	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—C3—glaucoma	4.75e-05	0.000859	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—FN1—glaucoma	4.69e-05	0.000848	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NGFR—glaucoma	4.66e-05	0.000842	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—BAD—glaucoma	4.64e-05	0.000838	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NGFR—glaucoma	4.56e-05	0.000824	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SMO—glaucoma	4.43e-05	0.0008	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NTRK1—glaucoma	4.43e-05	0.0008	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NTRK1—glaucoma	4.33e-05	0.000783	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—C3—glaucoma	4.32e-05	0.00078	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CDKN2B—glaucoma	4.08e-05	0.000737	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GSTM1—glaucoma	4.06e-05	0.000734	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NTRK2—glaucoma	4.05e-05	0.000732	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CDKN2B—glaucoma	3.99e-05	0.000722	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EDN1—glaucoma	3.91e-05	0.000707	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EDN1—glaucoma	3.83e-05	0.000693	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NOS3—glaucoma	3.73e-05	0.000674	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NGF—glaucoma	3.6e-05	0.00065	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MTHFR—glaucoma	3.59e-05	0.000648	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NGF—glaucoma	3.52e-05	0.000636	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NGFR—glaucoma	3.47e-05	0.000628	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—C3—glaucoma	3.42e-05	0.000618	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—C3—glaucoma	3.35e-05	0.000605	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOE—glaucoma	3.34e-05	0.000604	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CAV1—glaucoma	3.31e-05	0.000598	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NTRK1—glaucoma	3.3e-05	0.000597	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CDKN1B—glaucoma	3.23e-05	0.000584	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOE—glaucoma	3.18e-05	0.000575	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CAV1—glaucoma	3.15e-05	0.00057	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOE—glaucoma	3.12e-05	0.000563	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CAV1—glaucoma	3.09e-05	0.000558	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CDKN2B—glaucoma	3.04e-05	0.00055	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FN1—glaucoma	3e-05	0.000543	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MMP9—glaucoma	2.99e-05	0.000541	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—BAD—glaucoma	2.97e-05	0.000536	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FN1—glaucoma	2.94e-05	0.000531	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EDN1—glaucoma	2.92e-05	0.000528	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—BAD—glaucoma	2.9e-05	0.000525	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—VEGFA—glaucoma	2.69e-05	0.000486	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NGF—glaucoma	2.68e-05	0.000485	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—C3—glaucoma	2.55e-05	0.000461	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NOS3—glaucoma	2.5e-05	0.000452	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOS3—glaucoma	2.38e-05	0.000431	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOE—glaucoma	2.37e-05	0.000429	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CAV1—glaucoma	2.35e-05	0.000425	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOS3—glaucoma	2.34e-05	0.000422	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—glaucoma	2.29e-05	0.000414	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FN1—glaucoma	2.24e-05	0.000405	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—BAD—glaucoma	2.21e-05	0.0004	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CDKN1B—glaucoma	2.07e-05	0.000373	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TP53—glaucoma	2.03e-05	0.000367	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CDKN1B—glaucoma	2.02e-05	0.000366	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP9—glaucoma	1.91e-05	0.000346	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP9—glaucoma	1.87e-05	0.000339	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOS3—glaucoma	1.78e-05	0.000321	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—VEGFA—glaucoma	1.72e-05	0.00031	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—VEGFA—glaucoma	1.68e-05	0.000304	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CDKN1B—glaucoma	1.54e-05	0.000278	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP9—glaucoma	1.43e-05	0.000258	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TP53—glaucoma	1.3e-05	0.000235	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VEGFA—glaucoma	1.28e-05	0.000232	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TP53—glaucoma	1.27e-05	0.00023	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TP53—glaucoma	9.68e-06	0.000175	CbGpPWpGaD
